During the past decade, Clinical Research Institute of Southern Oregon, PC conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 20 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 8 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Institute of Southern Oregon, PC" #1 sponsor was "Pfizer" with 8 trials, followed by "Sunovion" with 6 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Sunovion Respiratory Development Inc." with 4 trials sponsored and "Chiesi Farmaceutici S.p.A." with 4 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Institute of Southern Oregon, PC" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Cephalon" with 1 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Institute of Southern Oregon, PC" are "Asthma" (16 trials), "Atopic Dermatitis" (7 trials), "Chronic Obstructive Pulmonary Disease" (7 trials), "COPD" (4 trials) and "Perennial Allergic Rhinitis" (4 trials). Many other conditions were trialed in "Clinical Research Institute of Southern Oregon, PC" in a lesser frequency.

Most popular intervention types in "Clinical Research Institute of Southern Oregon, PC" are "Drug" (55 trials), "Biological" (15 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Lebrikizumab" (5 trials), "placebo" (5 trials), "0.15% azelastine hydrochloride" (2 trials) and "Ciclesonide nasal aerosol 37 mcg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Institute of Southern Oregon, PC" are 69 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Institute of Southern Oregon, PC". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Clinical Research Institute of Southern Oregon, PC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Institute of Southern Oregon, PC, 1 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".